What is the recommended intramuscular (IM) medication for a patient experiencing a seizure in a psychiatric hospital?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Intramuscular Treatment for Seizures in a Psychiatric Hospital Setting

For an actively seizing patient when IV access is not immediately available, administer intramuscular midazolam 0.2 mg/kg (maximum 10 mg) as your first-line IM agent. 1

Why IM Midazolam is the Preferred Choice

IM midazolam is superior to other IM benzodiazepines because of its rapid absorption and proven efficacy. 2, 3 Unlike diazepam and lorazepam, which have erratic and slow absorption from intramuscular sites, midazolam is water-soluble and achieves therapeutic levels within 5-10 minutes of IM administration. 2, 4

  • Recent evidence demonstrates that IM midazolam is more effective than IV lorazepam in the prehospital setting, with 73.4% seizure cessation versus 63.4% for IV lorazepam (p < 0.001). 2
  • Midazolam reaches peak effect within 3-4 minutes when given IM, making it the fastest-acting intramuscular anticonvulsant available. 5
  • The dose can be repeated every 10-15 minutes if seizures continue, up to a maximum of 6 mg per dose in some protocols. 5

Why NOT Other IM Options

IM diazepam should be avoided entirely because WHO guidelines explicitly state that "intramuscular administration of diazepam is not recommended because of erratic absorption." 1

IM phenobarbital is only considered when rectal diazepam is not possible due to medical or social reasons, making it a distant second choice. 1 It has slower onset and higher risk of respiratory depression compared to midazolam. 3

IM lorazepam has slow absorption with Tmax of 1-2 hours, making it unsuitable for acute seizure management despite being effective intravenously. 2

Critical Safety Monitoring

  • Have airway equipment immediately available and monitor oxygen saturation continuously, as respiratory depression can occur with any benzodiazepine. 5, 6
  • Be prepared to provide respiratory support regardless of administration route, particularly if the patient has received other sedating medications. 5
  • Hypotension occurs in approximately 30% of patients receiving midazolam, so monitor blood pressure closely. 7

What to Do After IM Midazolam

If seizures continue 10-15 minutes after the first IM midazolam dose:

  • Repeat IM midazolam 0.2 mg/kg (maximum 6 mg) while attempting to establish IV access. 5
  • Once IV access is obtained, immediately administer a second-line agent: valproate 20-30 mg/kg IV (88% efficacy, 0% hypotension risk), levetiracetam 30 mg/kg IV (68-73% efficacy), or fosphenytoin 20 mg PE/kg IV (84% efficacy but 12% hypotension risk). 7

Common Pitfalls to Avoid

Never use neuromuscular blockers alone (such as rocuronium), as they only mask motor manifestations while allowing continued electrical seizure activity and ongoing brain injury. 7

Do not delay treatment to obtain IV access if it is difficult—IM midazolam is faster and more effective than delayed IV therapy. 2, 3

Check fingerstick glucose immediately while administering anticonvulsants, as hypoglycemia is a rapidly reversible cause of seizures. 7

Search for underlying causes simultaneously: hypoglycemia, hyponatremia, drug toxicity, CNS infection, stroke, or withdrawal syndromes. 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Intramuscular and rectal therapies of acute seizures.

Epilepsy & behavior : E&B, 2015

Research

Use of intramuscular midazolam for status epilepticus.

The Journal of emergency medicine, 1999

Guideline

Midazolam Pharmacokinetics and Administration

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Status Epilepticus Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.